Selected research
Industry Research
Obeticholic Acid Industry Research Report 2026
Market perspective
The global Obeticholic Acid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Obeticholic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Obeticholic Acid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Obeticholic Acid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Obeticholic Acid include Intercept Pharmaceuticals, Everest Pharmaceuticals and Beacon Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Obeticholic Acid market in terms of revenue (US$ million) and, where applicable, sales volume (W Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Obeticholic Acid Market by Company
Intercept Pharmaceuticals
Everest Pharmaceuticals
Beacon Pharma
Obeticholic Acid Segment by Type
5mg Tables
10mg Tables
Obeticholic Acid Segment by Application
Primary Biliary Cirrhosis
Nonalcoholic Fatty Liver Disease
Others
Obeticholic Acid Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Obeticholic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Obeticholic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Obeticholic Acid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Obeticholic Acid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Obeticholic Acid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Obeticholic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg Tables
- 10mg Tables
Applications
- Primary Biliary Cirrhosis
- Nonalcoholic Fatty Liver Disease
- Others
Companies covered
- Intercept Pharmaceuticals
- Everest Pharmaceuticals
- Beacon Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Obeticholic Acid Market Size (2021-2032)
- 2.2.2 Global Obeticholic Acid Sales (2021-2032)
- 2.2.3 Global Obeticholic Acid Market Average Price (2021-2032)
- 2.3 Obeticholic Acid by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 5mg Tables
- 2.3.3 10mg Tables
- 2.4 Obeticholic Acid by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Primary Biliary Cirrhosis
- 2.4.3 Nonalcoholic Fatty Liver Disease
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Obeticholic Acid Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Obeticholic Acid Sales (W Pcs) of Manufacturers (2021-2026)
- 3.3 Global Obeticholic Acid Revenue of Manufacturers (2021-2026)
- 3.4 Global Obeticholic Acid Average Price by Manufacturers (2021-2026)
- 3.5 Global Obeticholic Acid Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Obeticholic Acid, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Obeticholic Acid, Product Type & Application
- 3.8 Global Manufacturers of Obeticholic Acid, Established Date
- 3.9 Global Obeticholic Acid Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Intercept Pharmaceuticals
- 4.1.1 Intercept Pharmaceuticals Company Information
- 4.1.2 Intercept Pharmaceuticals Business Overview
- 4.1.3 Intercept Pharmaceuticals Obeticholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Intercept Pharmaceuticals Obeticholic Acid Product Portfolio
- 4.1.5 Intercept Pharmaceuticals Recent Developments
- 4.2 Everest Pharmaceuticals
- 4.2.1 Everest Pharmaceuticals Company Information
- 4.2.2 Everest Pharmaceuticals Business Overview
- 4.2.3 Everest Pharmaceuticals Obeticholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Everest Pharmaceuticals Obeticholic Acid Product Portfolio
- 4.2.5 Everest Pharmaceuticals Recent Developments
- 4.3 Beacon Pharma
- 4.3.1 Beacon Pharma Company Information
- 4.3.2 Beacon Pharma Business Overview
- 4.3.3 Beacon Pharma Obeticholic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Beacon Pharma Obeticholic Acid Product Portfolio
- 4.3.5 Beacon Pharma Recent Developments
5 Global Obeticholic Acid Market Scenario by Region
- 5.1 Global Obeticholic Acid Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Obeticholic Acid Sales by Region: 2021-2032
- 5.2.1 Global Obeticholic Acid Sales by Region: 2021-2026
- 5.2.2 Global Obeticholic Acid Sales by Region: 2027-2032
- 5.3 Global Obeticholic Acid Revenue by Region: 2021-2032
- 5.3.1 Global Obeticholic Acid Revenue by Region: 2021-2026
- 5.3.2 Global Obeticholic Acid Revenue by Region: 2027-2032
- 5.4 North America Obeticholic Acid Market Facts & Figures by Country
- 5.4.1 North America Obeticholic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Obeticholic Acid Sales by Country (2021-2032)
- 5.4.3 North America Obeticholic Acid Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Obeticholic Acid Market Facts & Figures by Country
- 5.5.1 Europe Obeticholic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Obeticholic Acid Sales by Country (2021-2032)
- 5.5.3 Europe Obeticholic Acid Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Obeticholic Acid Market Facts & Figures by Country
- 5.6.1 Asia Pacific Obeticholic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Obeticholic Acid Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Obeticholic Acid Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Obeticholic Acid Market Facts & Figures by Country
- 5.7.1 South America Obeticholic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Obeticholic Acid Sales by Country (2021-2032)
- 5.7.3 South America Obeticholic Acid Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Obeticholic Acid Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Obeticholic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Obeticholic Acid Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Obeticholic Acid Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Obeticholic Acid Sales by Type (2021-2032)
- 6.1.1 Global Obeticholic Acid Sales by Type (2021-2032) & (W Pcs)
- 6.1.2 Global Obeticholic Acid Sales Market Share by Type (2021-2032)
- 6.2 Global Obeticholic Acid Revenue by Type (2021-2032)
- 6.2.1 Global Obeticholic Acid Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Obeticholic Acid Revenue Market Share by Type (2021-2032)
- 6.3 Global Obeticholic Acid Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Obeticholic Acid Sales by Application (2021-2032)
- 7.1.1 Global Obeticholic Acid Sales by Application (2021-2032) & (W Pcs)
- 7.1.2 Global Obeticholic Acid Sales Market Share by Application (2021-2032)
- 7.2 Global Obeticholic Acid Revenue by Application (2021-2032)
- 7.2.1 Global Obeticholic Acid Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Obeticholic Acid Revenue Market Share by Application (2021-2032)
- 7.3 Global Obeticholic Acid Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Obeticholic Acid Value Chain Analysis
- 8.1.1 Obeticholic Acid Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Obeticholic Acid Production Mode & Process
- 8.2 Obeticholic Acid Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Obeticholic Acid Distributors
- 8.2.3 Obeticholic Acid Customers
9 Global Obeticholic Acid Analyzing Market Dynamics
- 9.1 Obeticholic Acid Industry Trends
- 9.2 Obeticholic Acid Industry Drivers
- 9.3 Obeticholic Acid Industry Opportunities and Challenges
- 9.4 Obeticholic Acid Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst